Table 1 Data collection and refinement statistics
BAFF/belimumab Fab | Belimumab Fab | |
|---|---|---|
Data collection | ||
X-ray source | PLS 5C | PLS 7A |
Wavelength (Å) | 1.0000 | 1.0000 |
Space group | P213 | P21 |
Cell dimensions | ||
a, b, c (Å) | 134.00, 134.00, 134.00 | 60.91, 52.30, 63.75 |
α, β, γ (°) | 90, 90, 90 | 90, 90.72, 90 |
Resolution (Å) | 2.05 (2.09–2.05)a | 1.90 (1.93–1.90) |
Rsym (%) | 8.3 (42.4) | 5.5 (25.3) |
I/σI | 51.6 (3.1) | 41.1 (4.3) |
Completeness (%) | 96.7 (95.9) | 97.7 (87.8) |
Redundancy | 14.5 (10.5) | 3.4 (2.6) |
Refinement | ||
Resolution (Å) | 2.05 | 1.90 |
No. reflections | 48,698 | 31,056 |
Rwork/Rfree (%) | 18.0/21.8 | 16.7/20.6 |
No. atoms | ||
Protein | 4331 | 3172 |
Water | 500 | 393 |
B-factors (Å2) | 38.4 | 29.9 |
R.m.s. deviation | ||
Bond lengths (Å) | 0.007 | 0.007 |
Bond angles (°) | 1.129 | 1.096 |
Ramachandran | ||
Favored (%) | 97.70 | 97.61 |
Allowed (%) | 2.13 | 2.39 |
Outlier (%) | 0.18 | 0.00 |
PDB ID code | 5Y9J | 5Y9K |